Sign in

You're signed outSign in or to get full access.

Margaret Wolff

About Margaret L. Wolff

Margaret L. Wolff (born 1955; Board Member since 2016) is an Independent Board Member of Nuveen Municipal Credit Opportunities Fund (NMCO) and across the Nuveen fund complex. A former Skadden, Arps, Slate, Meagher & Flom LLP M&A lawyer, she brings deep governance and fiduciary advisory experience; she currently chairs the Compliance, Risk Management and Regulatory Oversight Committee and serves on multiple board committees .

Past Roles

OrganizationRoleTenureCommittees/Impact
Skadden, Arps, Slate, Meagher & Flom LLP (Mergers & Acquisitions Group)Of Counsel2005–2014Advised boards and senior management on corporate, securities, governance, fiduciary and strategic matters .

External Roles

OrganizationRoleTenureNotes
New York-Presbyterian HospitalTrusteeSince 2005Board-level governance in major non-profit hospital system .
The John A. Hartford FoundationTrustee; ChairTrustee since 2004; Chair 2015–2022Philanthropy focused on care for older adults; chair service demonstrates governance leadership .
Travelers Insurance Co. of Canada; The Dominion of Canada General Insurance Co.Director2013–2017Part of Travelers Canada (The Travelers Companies, Inc.); prior public-company board experience .
Mount Holyoke CollegeTrustee; Vice ChairTrustee 2005–2015; Vice Chair 2011–2015Higher-education governance experience .

Board Governance

  • Independence: All current nominees and Board Members, including Wolff, are “Independent Board Members” (not “interested persons” under the 1940 Act; never employees/directors of TIAA, Nuveen, or affiliates) .
  • Election status (NMCO): For funds with Preferred Shares (including NMCO), Wolff is a nominee elected by holders of Preferred Shares for a term expiring at the next annual meeting or until a successor is elected and qualified .
  • Committee assignments:
    • Compliance, Risk Management and Regulatory Oversight Committee: Chair .
    • Audit Committee: Member (committee is all-independent; financial experts designated are Moschner, Nelson, Starr, Young—not Wolff) .
    • Nominating and Governance Committee: Member .
    • Investment Committee: Member .
    • Closed-End Fund Committee: Member .
  • Board attendance: Each Board Member attended at least 75% of Board and committee meetings during the last fiscal year .
  • Meeting cadence (NMCO last fiscal year): Regular Board 5; Special Board 7; Executive Committee 5; Dividend Committee 8; Compliance Committee 4; Audit Committee 14; Nominating & Governance 7; Investment Committee 3; Closed-End Fund Committee 4 .

Fixed Compensation

The Nuveen fund complex uses a cash retainer structure for independent directors, with committee retainers and chair stipends; directors may elect to defer fees.

Component2024 Amount2025 AmountNotes
Annual Independent Board Member retainer$350,000$350,000Effective Jan 1, 2024 .
Audit Committee membership retainer$30,000$35,000Effective Jan 1, 2025 increase .
Compliance Committee membership retainer$30,000$35,000Effective Jan 1, 2025 increase .
Investment Committee membership retainer$20,000$30,000Effective Jan 1, 2025 increase .
Dividend Committee membership retainer$20,000$25,000Effective Jan 1, 2025 increase .
Nominating & Governance membership retainer$20,000$25,000Effective Jan 1, 2025 increase .
Closed-End Funds Committee membership retainer$20,000$25,000Effective Jan 1, 2025 increase .
Board Chair stipend (not Wolff)$140,000$150,000Independent Chair stipend .
Committee Chair stipends (per committee)$20,000–$30,000$25,000–$35,000Compliance/Audit/Investment/Dividend/Nominating/Closed-End chair stipends .
Ad hoc/special assignment fees$1,000–$2,500 per meeting; chair/member quarterly fees start at $1,250/$5,000As needed .
Deferred Compensation PlanAvailableDirectors can defer fees into book accounts tracking Nuveen fund returns .

Director-level amounts paid (last fiscal year):

  • Aggregate compensation paid by NMCO to Wolff: $3,367 .
  • Total compensation from funds in the Fund Complex paid to Wolff: $535,644 .
  • NMCO deferred fees credited to Wolff’s book account (including investment return): $1,228 .

Performance Compensation

Independent directors receive no equity awards or performance-based incentives; no options, RSUs, PSUs, or TSR/EBITDA/ESG metrics apply.

ItemStatusMetric/Terms
Equity awards (RSUs/PSUs/options)None disclosedIndependent directors compensated via cash retainers; may elect fee deferrals only .
Performance metrics tied to director payNone disclosedNo revenue/EBITDA/TSR/ESG targets for directors .

Other Directorships & Interlocks

Company/InstitutionRolePotential Interlock/Conflict with NMCO
New York-Presbyterian HospitalTrusteeNon-profit; no apparent NMCO conflict .
The John A. Hartford FoundationTrustee; former ChairNon-profit; no apparent NMCO conflict .
Travelers Canada entitiesDirector (2013–2017)Prior role; no active interlock; unrelated to municipal fund adviser .
Mount Holyoke CollegeTrustee/Vice Chair (prior)Prior role; no apparent NMCO conflict .

Expertise & Qualifications

  • 30+ years advising boards and management on corporate governance, shareholder, fiduciary, and regulatory matters; extensive M&A legal background from Skadden .
  • Committee leadership (Compliance Committee Chair) evidences risk oversight expertise; broad participation across investment, audit, nom/gov, and closed-end oversight committees .
  • Education: B.A. Mount Holyoke College; J.D. Case Western Reserve University School of Law .

Equity Ownership

MeasureNMCOFund Complex
Beneficial shares owned0 Aggregate dollar range of equity securities across all registered investment companies overseen: Over $100,000 .
Ownership as % of NMCO outstanding0% (individual holdings <1%) Group of board members/officers: less than 1% in each fund .
Director ownership guidelineExpectation to invest at least one year of compensation in funds of the complex .
Pledged/hedged sharesNot disclosedNot disclosed.

Governance Assessment

  • Strengths

    • Independent status; never affiliated with TIAA/Nuveen; active chair of Compliance and member of key committees (Audit, Investment, Nom/Gov, Closed-End), supporting board effectiveness and risk oversight .
    • Engagement: NMCO’s board held frequent committee meetings (e.g., 14 Audit; 7 Nom/Gov) and all directors met the ≥75% attendance threshold, supporting governance continuity .
    • Transparent fee structure with committee retainers and disclosed increases, plus availability of deferred compensation aligned to fund returns .
  • Watch items / potential red flags

    • Zero direct ownership in NMCO despite a board principle to invest at least one year of compensation in the complex; aggregate holdings are “Over $100,000” across the complex, but the proxy does not disclose compliance vs. guideline—monitor alignment signals and future disclosures .
    • Audit Committee financial expert designation is held by other directors (Moschner, Nelson, Starr, Young); Wolff is not designated, which may modestly constrain audit oversight specialization though committee composition remains robust .
    • No related-party transactions disclosed for Wolff; Section 16(a) filings deemed compliant—continue monitoring for changes .
  • Board structure context

    • Unitary board overseeing the entire Nuveen fund complex enhances cross-fund policy consistency and leverage in oversight; independent Chair (Robert L. Young) provides an additional governance safeguard .

Additional Notes

  • Director compensation is entirely cash-based; no severance, change-of-control, clawback, tax gross-ups, or perquisites are disclosed for independent directors; the Funds have no employees and officers receive no compensation from the Funds .
  • Election mechanics: For NMCO, holders of Common and Preferred Shares vote together for certain class seats, while holders of Preferred Shares vote separately for two seats where Wolff is a nominee; plurality voting applies; broker discretionary voting rules described for certain preferred modes .